Limited Nutrient Availability in the Tumor Microenvironment Renders Pancreatic Tumors Sensitive to Allosteric IDH1 Inhibitors

The authors showed that allosteric inhibitors of mutant isocitrate dehydrogenase 1 (mIDH1) were potent wild-type IDH1 inhibitors under conditions present in the tumor microenvironment.